Stay updated on BOS-580 in NASH Obese Subjects Clinical Trial

Sign up to get notified when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BOS-580 in NASH Obese Subjects Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The webpage has removed specific dates and a notice regarding service performance issues, which may impact user experience.
    Difference
    2%
    Check dated 2025-02-24T20:31:45.000Z thumbnail image
  5. Check
    31 days ago
    No Change Detected
  6. Check
    39 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:41:01.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T06:20:52.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated to version v2.14.1, with new additions from January 2025, while the previous version v2.14.0 and several December 2024 entries have been removed.
    Difference
    0.9%
    Check dated 2025-01-19T21:38:42.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T17:14:08.000Z thumbnail image
  10. Check
    89 days ago
    Change Detected
    Summary
    The study has transitioned from BOS-580 to Efimosfermin, with updated dosing cohorts and a focus on safety, tolerability, and pharmacokinetics in obese participants with NASH.
    Difference
    22%
    Check dated 2024-12-21T20:25:03.000Z thumbnail image

Stay in the know with updates to BOS-580 in NASH Obese Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BOS-580 in NASH Obese Subjects Clinical Trial page.